REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Conditions
- Ovarian Cancer
- Advanced Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Primary Peritoneal Cancer
- PARP Inhibitor
- Fatigue Related to Cancer Treatment
- Fatigue in Cancer Survivors
Interventions
- BEHAVIORAL: REVITALIZE Intervention
- BEHAVIORAL: Educational Materials
Sponsor
Dana-Farber Cancer Institute
Collaborators